{"data":[{"accessionNo":"0002012383-26-003819","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001645469","issuerName":"MONOPAR THERAPEUTICS","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock","eventDate":"2026-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":338133,"percentOfClass":5.03,"filedAt":"2026-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0000919574-26-004969","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":324195,"percentOfClass":4.76,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0000919574-26-004969","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":324195,"percentOfClass":4.76,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0000919574-26-004969","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":324195,"percentOfClass":4.76,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0002060757-26-000047","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Saturn V Capital Management LP","reportingCik":null,"personType":"IA","sharesOwned":313384,"percentOfClass":4.7,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0002060757-26-000047","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock, $0.001 par value","eventDate":"2026-06-30","reportingPerson":"Xiaoying Tian","reportingCik":null,"personType":"IN","sharesOwned":313384,"percentOfClass":4.7,"filedAt":"2026-08-12","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001104659-26-062250","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock","eventDate":"2026-01-05","reportingPerson":"Saturn V Capital Management LP","reportingCik":null,"personType":"IA","sharesOwned":345626,"percentOfClass":5.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001104659-26-062250","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock","eventDate":"2026-01-05","reportingPerson":"Xiaoying Tian","reportingCik":null,"personType":"IN","sharesOwned":345626,"percentOfClass":5.2,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0000919574-26-002922","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Adage Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":424195,"percentOfClass":6.23,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0000919574-26-002922","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Robert Atchinson","reportingCik":null,"personType":"HC,IN","sharesOwned":424195,"percentOfClass":6.23,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0000919574-26-002922","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":"61023L207","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-03-31","reportingPerson":"Phillip Gross","reportingCik":null,"personType":"HC,IN","sharesOwned":424195,"percentOfClass":6.23,"filedAt":"2026-05-13","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001346824-26-000051","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":667632,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001346824-26-000051","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":667632,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001346824-26-000051","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":667632,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001346824-26-000051","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":667632,"percentOfClass":9.9,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001104659-26-011303","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"AstraZeneca PLC","reportingCik":null,"personType":"CO","sharesOwned":522667,"percentOfClass":7.8,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001104659-26-011303","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value per share","eventDate":"2025-12-31","reportingPerson":"Alexion Pharmaceuticals, Inc.","reportingCik":null,"personType":"CO","sharesOwned":522667,"percentOfClass":7.8,"filedAt":"2026-02-06","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001437749-26-002528","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-01-28","reportingPerson":"Robinson Chandler","reportingCik":"0001727334","personType":"IN","sharesOwned":307370,"percentOfClass":4.5,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001437749-26-002528","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-01-28","reportingPerson":"Brown Michael J","reportingCik":"0001035909","personType":"IN","sharesOwned":124629,"percentOfClass":1.8,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001437749-26-002528","formType":"SCHEDULE 13D/A","amendmentNo":3,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2026-01-28","reportingPerson":"Tactic Pharma LLC","reportingCik":"0001727357","personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001274173-25-000317","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001645469","issuerName":"MONOPAR THERAPEUTICS INC","ticker":"MNPR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"JANUS HENDERSON GROUP PLC","reportingCik":null,"personType":"IA,HC","sharesOwned":1287368,"percentOfClass":19.5,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001274173-25-000317","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001645469","issuerName":"MONOPAR THERAPEUTICS INC","ticker":"MNPR","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Janus Henderson Biotech Innovation Master Fund Ltd","reportingCik":null,"personType":"IV","sharesOwned":1105471,"percentOfClass":16.7,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001231919-25-000489","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":742861,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001231919-25-000489","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":742861,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001231919-25-000489","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":742861,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001231919-25-000489","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics Inc.","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-09-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":742861,"percentOfClass":9.9,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001437749-25-029839","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-24","reportingPerson":"Robinson Chandler","reportingCik":"0001727334","personType":"IN","sharesOwned":506199,"percentOfClass":7.5,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001437749-25-029839","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-24","reportingPerson":"Brown Michael J","reportingCik":"0001035909","personType":"IN","sharesOwned":338067,"percentOfClass":5.1,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001437749-25-029839","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-24","reportingPerson":"Tactic Pharma LLC","reportingCik":"0001727357","personType":"OO","sharesOwned":272026,"percentOfClass":4.1,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001437749-25-029839","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-24","reportingPerson":"Mazar Andrew Paul","reportingCik":"0001727393","personType":"IN","sharesOwned":272026,"percentOfClass":4.1,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"},{"accessionNo":"0001437749-25-029839","formType":"SCHEDULE 13D/A","amendmentNo":2,"issuerCik":"0001645469","issuerName":"Monopar Therapeutics","ticker":"MNPR","cusip":null,"securityClass":"Common Stock, $0.001 par value","eventDate":"2025-09-24","reportingPerson":"O'Halloran Thomas V.","reportingCik":"0001727481","personType":"IN","sharesOwned":272026,"percentOfClass":4.1,"filedAt":"2025-09-24","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr"}],"updatedAt":"2026-11-05T16:29:44.544Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/mnpr","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}